Intel Co. (NASDAQ:INTC) Holdings Raised by Sicart Associates LLC

Share on StockTwits

Sicart Associates LLC boosted its stake in Intel Co. (NASDAQ:INTC) by 62.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 204,538 shares of the chip maker’s stock after buying an additional 78,785 shares during the period. Intel accounts for approximately 5.3% of Sicart Associates LLC’s investment portfolio, making the stock its 4th largest holding. Sicart Associates LLC’s holdings in Intel were worth $10,168,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of INTC. TIAA CREF Investment Management LLC increased its position in Intel by 47.8% in the fourth quarter. TIAA CREF Investment Management LLC now owns 23,711,209 shares of the chip maker’s stock worth $1,094,509,000 after buying an additional 7,669,737 shares during the period. Renaissance Technologies LLC increased its position in Intel by 3,222.2% in the fourth quarter. Renaissance Technologies LLC now owns 3,441,594 shares of the chip maker’s stock worth $158,864,000 after buying an additional 3,338,000 shares during the period. Platinum Investment Management Ltd. increased its position in Intel by 192.0% in the first quarter. Platinum Investment Management Ltd. now owns 4,712,431 shares of the chip maker’s stock worth $245,423,000 after buying an additional 3,098,600 shares during the period. Alliancebernstein L.P. increased its position in Intel by 14.7% in the fourth quarter. Alliancebernstein L.P. now owns 24,187,824 shares of the chip maker’s stock worth $1,116,510,000 after buying an additional 3,095,697 shares during the period. Finally, Millennium Management LLC increased its position in Intel by 232.8% in the first quarter. Millennium Management LLC now owns 1,750,545 shares of the chip maker’s stock worth $91,168,000 after buying an additional 3,069,040 shares during the period. 65.37% of the stock is currently owned by hedge funds and other institutional investors.

INTC stock traded up $0.65 during trading hours on Friday, hitting $44.88. 31,748,529 shares of the stock traded hands, compared to its average volume of 29,322,836. Intel Co. has a one year low of $39.28 and a one year high of $57.60. The stock has a market capitalization of $221.24 billion, a P/E ratio of 12.97, a P/E/G ratio of 1.35 and a beta of 0.97. The company has a quick ratio of 1.15, a current ratio of 1.57 and a debt-to-equity ratio of 0.35.

Intel (NASDAQ:INTC) last announced its earnings results on Thursday, July 26th. The chip maker reported $1.04 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.99 by $0.05. Intel had a return on equity of 27.33% and a net margin of 20.07%. The business had revenue of $16.96 billion during the quarter, compared to analysts’ expectations of $16.78 billion. During the same quarter last year, the business posted $0.72 earnings per share. The company’s quarterly revenue was up 14.9% on a year-over-year basis. On average, sell-side analysts anticipate that Intel Co. will post 4.15 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Saturday, December 1st. Investors of record on Wednesday, November 7th will be given a $0.30 dividend. The ex-dividend date is Tuesday, November 6th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 2.67%. Intel’s dividend payout ratio (DPR) is 34.68%.

In related news, EVP Steven Ralph Rodgers sold 1,251 shares of the stock in a transaction on Thursday, August 2nd. The stock was sold at an average price of $48.37, for a total value of $60,510.87. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Robert Holmes Swan purchased 5,243 shares of the firm’s stock in a transaction that occurred on Monday, July 30th. The stock was bought at an average price of $47.69 per share, with a total value of $250,038.67. Following the transaction, the chief executive officer now directly owns 71,672 shares in the company, valued at $3,418,037.68. The disclosure for this purchase can be found here. Insiders sold a total of 4,077 shares of company stock valued at $205,757 in the last quarter. 0.03% of the stock is currently owned by corporate insiders.

Several brokerages have weighed in on INTC. Stifel Nicolaus reaffirmed a “neutral” rating and issued a $60.00 target price on shares of Intel in a research report on Monday, July 16th. Cowen dropped their target price on Intel from $54.00 to $52.00 and set a “market perform” rating on the stock in a research report on Friday, July 27th. Wells Fargo & Co lowered their price target on Intel from $58.00 to $55.00 and set a “buy” rating on the stock in a report on Monday, September 10th. Macquarie reissued a “buy” rating and set a $60.00 price target on shares of Intel in a report on Monday, September 10th. Finally, Royal Bank of Canada reissued a “neutral” rating and set a $60.00 price target on shares of Intel in a report on Monday, July 16th. Six investment analysts have rated the stock with a sell rating, seventeen have issued a hold rating and twenty have assigned a buy rating to the company. Intel has a consensus rating of “Hold” and a consensus target price of $55.08.

Intel Profile

Intel Corporation designs, manufactures, and sells computer, networking, data storage, and communication platforms worldwide. The company operates through Client Computing Group, Data Center Group, Internet of Things Group, Non-Volatile Memory Solutions Group, Programmable Solutions Group, and All Other segments.

Featured Story: How can investors find ex-dividend dates?

Institutional Ownership by Quarter for Intel (NASDAQ:INTC)

Receive News & Ratings for Intel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intel and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.